Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2023

Dec 12, 2023

32093_dirs_2023-12-11_2e20fcf3-42b7-4bac-b492-116b98a11059.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-12-07

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-07 Common Stock P 74852 $9.19 Acquired 36759406 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 351565 Indirect
Common Stock 492069 Indirect

Footnotes

F1: Volume-weighted average price.

F2: Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.

F3: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.